Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology
Rev. bras. ter. intensiva; 32 (2), 2020
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Infecções por Coronavirus/tratamento farmacológico, Aminoquinolinas/uso terapêutico, Oseltamivir/uso terapêutico, Lopinavir/uso terapêutico, Ritonavir/uso terapêutico, Corticosteroides/uso terapêutico, Heparina/uso terapêutico, Antibacterianos/uso terapêutico, Betacoronavirus/efeitos dos fármacos, Pneumonia Viral/tratamento farmacológico, Pandemias/prevenção & controle